Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc shares valued at $275,425 were sold by Dickinson Andrew D on Jun 16 ’25. At $110.17 per share, Dickinson Andrew D sold 2,500 shares. The insider’s holdings dropped to 165,110 shares worth approximately $17.49 million following the completion of this transaction.
Also, Mercier Johanna sold 3,000 shares, netting a total of over 330,510 in proceeds. Following the sale of shares at $110.17 each, the insider now holds 120,168 shares.
Before that, JOHANNA MERCIER had added 3,000 shares to its account. In a trade valued at $330,510, the Officer bought Gilead Sciences, Inc shares for $110.17 each.
Analysts at Oppenheimer resumed the stock at ‘”an Outperform”‘ outlook in a report released in early March. As of February 18, 2025, Deutsche Bank has increased its “Hold” rating to a “Buy” for GILD. Earlier on February 13, 2025, DZ Bank upgraded its rating. Their new recommendation was “a Buy” for GILD stock which previously was a “a Hold”.
Analyzing GILD Stock Performance
On last trading session,, Gilead Sciences, Inc [NASDAQ: GILD] plunged -1.18% to $105.93. The stock’s lowest price that day was $104.46, but it reached a high of $106.92 in the same session. During the last five days, there has been a drop of approximately -1.92%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 49.89%. Shares of the company reached a 52-week high of $119.96 on 03/10/25 and a 52-week low of $88.57 on 01/10/25.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 104.62, which, if violated, would cause prices to drop to 103.31. In the upper region, resistance lies at 107.08. The next price resistance is at 108.23. RSI (Relative Strength Index) is 44.80 on the 14-day chart, showing neutral technical sentiment.
Is Gilead Sciences, Inc subject to short interest?
Stocks of Gilead Sciences, Inc saw a sharp steep in short interest on 2025-05-30 dropping by -2.64 million shares to 20.94 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 23.57 million shares. A decline of -12.6% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.39 of the overall float, the days-to-cover ratio (short ratio) decline to 2.39.
Which companies own the most shares of Gilead Sciences, Inc (GILD)?
In terms of Gilead Sciences, Inc share price expectations, FactSet research, analysts set an average price target of 126 in the next 12 months, up nearly 17.54% from the previous closing price of $107.2. Analysts anticipate Gilead Sciences, Inc stock to reach 135 by 2025, with the lowest price target being 83. In spite of this, 17 analysts ranked Gilead Sciences, Inc stock as Buy at the end of 2025. On January 10, 2025, Morgan Stanley assigned a price target of “an Overweight” to the stock and upgraded coverage with a $113.
